P. García-Navas

Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine

J. C. Barrera, X. Díaz-Villamarín, C. Dávila-Fajardo, 2019, Genes.

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

M. Pirmohamed, A. Cambon-Thomsen, Yitian Zhou, 2023, The Lancet.

Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis

X. Díaz-Villamarín, C. Dávila-Fajardo, L. J. Martínez-González, 2020, Genes.